Great Bay Bio attaches great importance to the frequently asked questions by clients.

Big data mining techniques, AI algorithms such as deep machine learning and transfer learning are used to construct the culture media formulation prediction model.

Process Flow


Platform Introduction

AlfaMedX is a cell culture media development platform of Great Bay Bio, which allows us to develop customized culture media for different cell lines in a short period of time, saving development cost and time.

Empowered by AI technology, we are able to significantly shorten the development cycle and increase the culture media quality.

Platform Values


The platform implements a one-stop service for developing cell culture media, and is open to a variety of cooperation models to meet clients' needs.

Business Model


Provide one-stop services for media production, medium formula licensing and cell line development

Zero-risk Business Model

  • No need to provide cell lines or related information


  • Customize cell media to meet specific needs of customers

    Technical alignment

  • With pay-after-satisfaction model

    Flexible payment

Frequently asked questions

Q. How long does it take to develop the cell medium?


A: Usually 2 to 3 months after receiving the cell line.




Q. What information should customers provide?


A: To develop the media, customers should provide information about cell line types (such as CHO, Vero137, and HEK293, etc.) and the used media for cell culture.




Q. What’s the advantage of AlfaMedX?


A: Based on deep learning of AI technologies, AlfaMedX can develop high-quality media in a short time with few experiment data. 

    Compared with traditional methods, it can significantly cut development time.




Q. What’s the service model of AlfaMedX?


A: The platform can provide customers with customized medium products or medium formulations, including formulation ingredients and preparation methods, etc.

Platform Introduction

Independently developed by Great Bay Bio, AlfaMedX is a biotechnology service platform for cell culture media development. Combining AI, big data and biomedicine techniques, it constructs an AI model to calculate the ratio of medium components, pH value, osmotic pressure, intermediate parameters, etc. It is able to develop high-quality customized media within a short time. Meanwhile, a variety of services are available and the zero-risk business model can address customers' concerns.

Platform Value

Develop better media with less experiments


Significantly shorten development time


Customized media formulation


Improve cell expression


Provide cell media or medium formula


More affordable and reliable supply chain